Article Details

Day One Biopharmaceuticals Raises $130M in Series B Funding

Retrieved on: 2021-02-10 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

Day One Biopharmaceuticals Raises $130M in Series B Funding. View article details on hiswai:

Excerpt

NEW YORK – Day One Biopharmaceuticals, a company developing targeted cancer treatments for children, said on Wednesday it has raised $130 ...

Article found on: www.precisiononcologynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up